Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 17 (2) , 263-270
- https://doi.org/10.1016/0197-0186(90)90148-m
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinePublished by Elsevier ,2003
- Oxidation of tertiary amines by monoamine oxidasesJournal of Pharmacy and Pharmacology, 1989
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSFBrain Research, 1987
- Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeysNeuroscience, 1986
- Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeysBrain Research, 1986
- Monoamine metabolites: Their relationship and lack of relationship to monoaminergic neuronal activityBiochemical Pharmacology, 1985
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973
- Tyrosine hydroxylase in rat brain—cofactor requirements, regional and subcellular distributionBiochemical Pharmacology, 1972